» Articles » PMID: 19701241

Normal and Cancer-related Functions of the P160 Steroid Receptor Co-activator (SRC) Family

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2009 Aug 25
PMID 19701241
Citations 280
Authors
Affiliations
Soon will be listed here.
Abstract

The three homologous members of the p160 SRC family (SRC1, SRC2 and SRC3) mediate the transcriptional functions of nuclear receptors and other transcription factors, and are the most studied of all the transcriptional co-activators. Recent work has indicated that the SRCgenes are subject to amplification and overexpression in various human cancers. Some of the molecular mechanisms responsible for SRC overexpression, along with the mechanisms by which SRCs promote breast and prostate cancer cell proliferation and survival, have been identified, as have the specific contributions of individual SRC family members to spontaneous breast and prostate carcinogenesis in genetically manipulated mouse models. These studies have identified new challenges for cancer research and therapy.

Citing Articles

Structural basis for the asymmetric binding of coactivator SRC1 to FXR-RXRα and allosteric communication within the complex.

Sheng Y, Guo Y, Zhao B, Sun M, Dong Y, Yin Y Commun Biol. 2025; 8(1):425.

PMID: 40082595 PMC: 11906777. DOI: 10.1038/s42003-025-07854-x.


Acetyltransferase in cardiovascular disease and aging.

Keller M, Nakamura M J Cardiovasc Aging. 2025; 4(26).

PMID: 39958699 PMC: 11827898. DOI: 10.20517/jca.2024.21.


Mechanisms of endocrine resistance in hormone receptor-positive breast cancer.

Gao Y, Yu Y, Zhang M, Yu W, Kang L Front Oncol. 2024; 14:1448687.

PMID: 39544302 PMC: 11560879. DOI: 10.3389/fonc.2024.1448687.


Function of Steroid Receptor Coactivators in T Cells and Cancers: Implications for Cancer Immunotherapy.

Zhang W, Cao X, Wu H, Zhong X, Shi Y, Sun Z Crit Rev Immunol. 2024; 44(6):111-126.

PMID: 38848298 PMC: 11902286. DOI: 10.1615/CritRevImmunol.2024051613.


The multifaceted therapeutic value of targeting steroid receptor coactivator-1 in tumorigenesis.

Chen Q, Guo P, Hong Y, Mo P, Yu C Cell Biosci. 2024; 14(1):41.

PMID: 38553750 PMC: 10979636. DOI: 10.1186/s13578-024-01222-8.


References
1.
Ye X, Han S, Tsai S, DeMayo F, Xu J, Tsai M . Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proc Natl Acad Sci U S A. 2005; 102(27):9487-92. PMC: 1172261. DOI: 10.1073/pnas.0503577102. View

2.
Lahusen T, Fereshteh M, Oh A, Wellstein A, Riegel A . Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Cancer Res. 2007; 67(15):7256-65. PMC: 3656436. DOI: 10.1158/0008-5472.CAN-07-1013. View

3.
Reiter R, Wellstein A, Riegel A . An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer. J Biol Chem. 2001; 276(43):39736-41. DOI: 10.1074/jbc.M104744200. View

4.
Giamas G, Castellano L, Feng Q, Knippschild U, Jacob J, Thomas R . CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions. Nucleic Acids Res. 2009; 37(9):3110-23. PMC: 2685087. DOI: 10.1093/nar/gkp136. View

5.
Wu R, Qin J, Yi P, Wong J, Tsai S, Tsai M . Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell. 2004; 15(6):937-49. DOI: 10.1016/j.molcel.2004.08.019. View